CompletedPhase 2NCT02493725

JET-GBS - Japanese Eculizumab Trial for GBS

Studying Functional variant of Guillain-Barré syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chiba University
Principal Investigator
Satoshi Kuwabara, MD
Chiba University Graduate School of Medicine Department of neurology
Intervention
Eculizumab(drug)
Enrollment
34 enrolled
Eligibility
18-99 years · All sexes
Timeline
20152016

Study locations (13)

Collaborators

Japan Agency for Medical Research and Development

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02493725 on ClinicalTrials.gov

Other trials for Functional variant of Guillain-Barré syndrome

Additional recruiting or active studies for the same condition.

See all trials for Functional variant of Guillain-Barré syndrome

← Back to all trials